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Objective: Endovascular repair of ruptured abdominal aortic aneurysm (rEVAR) has been shown to improve perioperative
outcomes compared with open surgical repair (OSR). Follow-up of these patients, however, is lacking. In this study, we
compare the discharge disposition and midterm survival of ruptured aneurysm patients who survived treatment with
either rEVAR or OSR.
Methods:We performed an institutional review board-approved, single-institution, retrospective review of all patients with
ruptured abdominal aortic aneurysms (rAAAs) admitted from July 2007 to February 2012. Primary outcomes were
discharge disposition and midterm survival (>30 days after the index operation). We also evaluated compliance with
follow-up and prevalence of endoleak.
Results: A total of 118 patients were analyzed. Eight patients received only comfort care, 10 died in the operating room,
39 underwent OSR, and 61 had rEVAR. Average age and sex were similar (OSR, 776 7.8 years, 85% male; rEVAR, 746
7.4 years, 79% male). Seventy-two survived to discharge (54% OSR [21/39]; 84% rEVAR [51/61]; P [ .001). OSR
patients had longer lengths of intensive care unit and total length of stay than rEVAR (11.8 6 10.4/23 6 16.4 days vs
6.3 6 8.5/12.3 6 13.0 days; P[ .002/.02). Only 19% (4/21) of patients were discharged home after OSR, rather than
to a skilled nursing facility. Signiﬁcantly more rEVAR patients were discharged to home rather than a skilled nursing
facility (65%; 33/51) (P[ .0004). Overall, the follow-up rate for determination of survival for patients who lived past 30
days was 86% (56/65; median, 14 months; 25th-75th interquartile, 3.1-27.8). Multivariable logistic regression revealed
only the type of procedure performed and perioperative hypotension predicted discharge destination. Kaplan-Meier
analysis revealed a signiﬁcant midterm survival beneﬁt for patients after rEVAR compared with OSR (P [ .01, log-
rank). Subgroup analysis of survivors past 30 days revealed similar rates of midterm survival (P[ .7, log-rank). Overall,
midterm relative risk reduction for death after rEVAR vs OSR was 35% (95% conﬁdence interval, 0.06-0.59).
Conclusions: We have previously demonstrated that successful utilization of rEVAR improves the early survival of rAAA
patients compared with OSR. This study shows that more patients are able to be discharged to home after rEVAR and
that the early survival advantage is continued in midterm follow-up, suggesting that rEVAR should be attempted ﬁrst
when feasible. Further studies are needed to determine the long-term durability of endovascular repair in the management
of rAAA as well as the impact on cost and long-term quality of life. (J Vasc Surg 2013;57:1495-502.)Although endovascular repair of ruptured abdominal
aortic aneurysms (rEVAR) was shown to be technically
feasible almost 20 years ago, only in the past decade has
it become an accepted approach.1-3 The data in support
of rEVAR are compelling but are mainly retrospective peri-
operative and early outcome investigations.4-8 Despite the
large amount of data favoring rEVAR in terms of early
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://dx.doi.org/10.1016/j.jvs.2012.11.089are limited and have shown mixed results.9-11 A recent
study comparing 37 patients who underwent rEVAR and
111 propensity matched patients who underwent OSR
demonstrated no mid- or late-term survival advantage for
rEVAR. More studies are needed to determine if the
improved early outcomes following rEVAR are limited or
can extend into the mid- and later-term follow-up
compared with OSR.12-15
Our early experience with rEVAR has been encour-
aging. In 2010, we reported a highly signiﬁcant reduction
in 30-day mortality following the implementation of
a structured rEVAR-ﬁrst algorithm (35% relative risk
reduction).16
The purpose of this study is to determine the effect of
rEVAR vs OSR on the discharge disposition, midterm
survival, endoleak prevalence, and follow-up of patients
who survived initial repair of a ruptured abdominal aortic
aneurysm (rAAA).
METHODS
This is a single-institution, retrospective review that
was approved by the institutional review board at the1495
Fig 1. Structured algorithm for managing patients with ruptured abdominal aortic aneurysms (rAAAs). AOB, Aortic
occlusion balloon; CT, computed tomography; CTA, computed tomographic angiography; GETA, general endotra-
cheal anesthesia; IVUS, intravascular ultrasound; OSH, outside hospital; rEVAR, endovascular repair of ruptured
abdominal aortic aneurysm.
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admitted to Harborview Medical Center with the diagnosis
of rAAA between July 1, 2007 and February 15, 2012 were
included. This time period followed the implementation of
a structured and previously described rEVAR-ﬁrst protocol
(Fig 1).16 Brieﬂy, patients are differentiated based on
hemodynamics and mentation. We allow for permissive
hypotension as long as patients are mentating. A computed
tomography (CT) scan is obtained for stable patients who
do not have imaging. Patients with imaging or who are
unstable go directly to the operating room (OR), bypassing
the emergency department. Once in the OR, an aortic
occlusion balloon is placed and inﬂated to proﬁle for those
patients with hemodynamic instability. rEVAR is attempted
ﬁrst in all patients with suitable anatomy and appropriate
patients are done under local or no anesthesia. Decompres-
sion laparotomy is performed for abdominal compartment
syndrome when indicated. In these cases, the retroperito-
neal space is not opened, and the retroperitoneal hema-
toma not evacuated. The abdomen is left open and the
patient is taken back to the operating room every 1-2
days until fascial closure is achieved. All patients are
admitted to the surgical intensive care unit postoperatively.
Demographic, perioperative, and follow-up characteris-
tics were assessed including age, sex, zip code, preoperative
hypotension (deﬁned as a single systolic blood pressure
<90 mm Hg), admission arterial lactate level, hospital and
intensive care unit (ICU) length of stay (LOS), clinicalfollow-up dates, CT angiography obtained at follow-up,
secondary procedures and reintervention, discharge destina-
tions, and dates of death. Days in the ICU following rEVAR
or OSR until transfer to the surgical ﬂoor were included in
the determination of ICU LOS. Factors inﬂuencing
30-day survival were reviewed and analyzed in a previous
publication from our institution.16 Patients discharged alive
who had not had a recent clinic appointment with us were
determined to be dead or alive by search of a national death
certiﬁcate database. If they were not found in this database,
telephone contact was attempted twice using the contact
information in their medical record. Patients who were
unable to be contacted were censored at the time of last
known contact.
Primary endpoints were discharge destination and
Kaplan-Meier survival. Secondary endpoints included clin-
ical follow-up, presence of endoleak (for patients who
underwent rEVAR), and complications after discharge
following open repair. LOS, survival, and discharge dis-
position were compared in rEVAR patients who did or did
not require either decompression laparotomy or femoral-
femoral bypass.
Categorical demographic variables were analyzed using
c2 analysis. Continuous parametric demographic variables
were evaluated using an unpaired, two-tailed Student
t-test. Nonparametric variables were compared using the
Mann-Whitney test. Multivariable logistic regression and
Kaplan-Meier survival distribution analysis were performed
Fig 2. Patient inclusion and exclusion for analysis. rAAA,
Ruptured abdominal aortic aneurysm; rEVAR, endovascular repair
of ruptured abdominal aortic aneurysm.
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tical package for Microsoft Excel. P values of <.05 were
considered statistically signiﬁcant for all analyses.
RESULTS
A total of 118 patients were admitted to our facility
with the diagnosis of rAAA during the study period
(Fig 2). Eight patients (6.8%) underwent comfort care,
a decision that was made for patients who had a living
will or by a legal surrogate who was in contact with our
team. Ten patients (8.5%) died in the operating room prior
to or during attempted repair; these were patients who pre-
sented in extremis and, despite an attempt to save their
lives, died as detailed in Table I. One hundred patients
survived the index operation; 39 underwent OSR and
61 were treated with rEVAR. The average age of the
open group was 77 6 7.8 years with 33 male patients
(85%), and the average age of the endovascular group
was 74 6 7.4 years with 48 male patients (79%)
(Table II). Seven of the 39 OSR group had been converted
to open repair after a failed endovascular attempt: ﬁve due
to unfavorable anatomy, speciﬁcally tortuosity and exten-
sive calciﬁcation of the iliac arteries, one due to loss of pulse
with an aortic occlusion balloon in place, and one taken
back on postoperative day zero for surgical evaluation ofcontinued bleeding and hemodynamic instability. Of the
conversions, only one survived to discharge (14% perioper-
ative survival). In the endovascular group, four patients
underwent concomitant decompression laparotomy, one
patient underwent both decompression laparotomy and
femoral-femoral bypass, and seven patients underwent
uni-iliac rEVAR with femoral-femoral bypass.
Preoperative hypotension was present in 64% (25/39)
of the OSR group and 62% (38/61) of the rEVAR patients
(P ¼ .85). Admission arterial lactate levels were on average
elevated and similar between patients who underwent OSR
compared with rEVAR (4.8 6 4.0 vs 3.9 6 3.4 mmol/L;
P ¼ .45). Admission lactic acidosis was similar between
survivors to discharge following OSR and rEVAR (2.7 6
2.8 vs 3.2 6 2.6 mmol/L; P ¼ .51).
Seventy-two of the 100 patients who survived the
index operation survived to discharge: 54% (21/39) after
OSR and 84% after rEVAR (51/61) (P ¼ .001). Average
hospital LOS was 12.3 6 13.0 days for the rEVAR group
and 23 6 16.4 days for the OSR group (P ¼ .002).
Average ICU LOS following rEVAR was 6.3 6 8.5 days
and after OSR was 11.8 6 10.4 days (P ¼ .02). Patients
who underwent rEVAR alone had signiﬁcantly shorter
hospital LOS than patients who also underwent decom-
pression laparotomy or femoral-femoral bypass (10.1 6
11.6 vs 21.4 6 15.3 days; P ¼ .01).
Of those who survived to discharge, 51% (37/72) went
home and 49% (35/72) were discharged to a skilled
nursing facility (SNF). The majority of rEVAR patients
were discharged home (65%, 33/51) vs 19% (4/21) of
the OSR group (P ¼ .0004) (Fig 3). A signiﬁcantly higher
proportion of patients who underwent femoral-femoral
bypass or decompression laparotomy at the time of rEVAR
were discharged to an SNF compared with patients who
underwent rEVAR alone (67% vs 29%; P ¼ .001). Patients
who underwent strictly rEVAR on average had a shorter
LOS than patients who underwent additional procedures
(10.1 6 11.6 vs 21.4 6 15.3 days; P ¼ .01). Patients
who underwent decompression laparotomy in addition to
rEVAR were less likely to survive to discharge compared
to rEVAR without decompression (60% vs 86%).
Twenty-three patients died after discharge from the
hospital. Seven of these patients died within 30 days of
discharge, three (14.3%) in the open surgical group, and
four (7.8%) in the endovascular group. Unfortunately, the
cause of death was not determined in this group. Of the
16 that died after 30 days, four were in the open surgical
group (death at postoperative month 1.8, 26, 35, and 47)
and 12 were in the endovascular group (six within the ﬁrst
6 months, three within the second 6 months, and three at
21, 29, and 42 months). A signiﬁcantly higher proportion
of rEVAR patients discharged to an SNF vs home died in
the follow-up period (61% vs 18% of deaths; P ¼ .003).
Overall, the follow-up rate for determination of survival
for patients who lived past 30 days was 86% (56/65) with
a median length of follow-up of 14 months (25th-75th
interquartile, 3.1-27.8). Median follow-up after rEVAR
was 16.3 months and after OSR was 12.4 months
Table II. Demographic characteristics of patients that survived their index procedure for rAAA
OSR (n ¼ 39) rEVAR (n ¼ 61) P
Age 6 SD, years 77.4 6 7.8 74.4 6 7.4 .069
Age >80 years 18 (46) 13 (21) <.01
Sex
Males 33 (85) 48 (79) .46
Females 6 13
Preoperative hypotension (SBP <90 mm Hg) 25 (64) 38 (62) .85
Admission arterial lactate 6 SD, mmol/L 4.8 6 4.0 3.9 6 3.4 .45
Length of stay 6 SD, days 23 6 16.4 12.3 6 13.0 <.01
ICU length of stay 6 SD, days 11.8 6 10.4 6.3 6 8.5 .02
Transfer from OSH 20 (51) 40 (66) .15
Median prehospital time, hours (25th-75th interquartile) 8.8 (2.0-18.0) 2.8 (1.2-16.1) .30
Median prehospital time to our institution, hours (25th-75th interquartile) 14.4 (6.6-19.7) 6.8 (4.2-22.3) .20
Median distance from our institution, miles (25th-75th interquartile) 39.4 (14.5-63.3) 20.3 (11.8-51.0) .29
Antecedent aortic intervention 4 (10) 7 (11) .85
Survival to discharge 21 (54) 51 (84) <.01
30-day survival 18 (46) 47 (77) <.01
Median f/u for determination of midterm survival, months (25th-75th
interquartile)
16.3 (3.1-27.9) 12.4 (3.1-24.8) .8
Median clinical follow-up, months (25th-75th interquartile) 0.9 (0.5-2) 1.6 (1.0-10.8) .14
f/u, Follow-up; ICU, intensive care unit; OSH, outside hospital; OSR, open surgical repair; rAAA, ruptured abdominal aortic aneurysm; rEVAR, endovascular
repair of ruptured abdominal aortic aneurysm; SBP, systolic blood pressure; SD, standard deviation.
Mean prehospital time was deﬁned as time from symptom onset to admission at any hospital. Mean prehospital time to our institution was deﬁned as time from
symptom onset to admission at our hospital, including time spent at outside hospitals beforehand.
Continuous data are given as median (range) and categoric data as number (%).
Table I. Summary of excluded intraoperative deaths
Patient Intervention Events leading to intraoperative death
1 Aortic control AOB placed, balloon dependent, inner cool IVC catheter placed, laparotomy, AOB rupture, manual
aortic control, AOB replaced, aneurysm sac entered, death
2 Aortic control Arrested on transfer to OR table, AOB unable to be placed, laparotomy, manual aortic control,
CPR, death
3 Aortic control AOB unable to be placed, ongoing CPR, laparotomy, aortic control, death
4 Aortic control Arrested on transport from CT, AOB placed, death
5 Aortic control Laparotomy, cross-clamp, death
6 Aortic control Arrested on transfer to OR table, 40 minutes CPR, attempted AOB, death
7 Attempted
OSR
Arrested with proximal aortic dissection, arrested with distal anastomosis, signiﬁcant bleeding from
proximal anastomosis, ﬁve cycles CPR, 2 hours intermittent supraceliac clamp time, death
8 Attempted
OSR
AOB unable to be placed, laparotomy, manual proximal aortic control, arrested, coagulopathic and
hypothermic to 30C, arrested and died as proximal anastomosis completed
9 Attempted
rEVAR
rEVAR, remained balloon dependent, TEE consistent with MI, decompression laparotomy,
intraoperative family discussion revealed the patient had metastatic cancer and had hoped to die
from rupture of known AAA, AOB deﬂated, death
10 Attempted
rEVAR
AOB placed and balloon dependent, arrested before device deployment, device deployed, decompression
laparotomy, death
AAA, Abdominal aortic aneurysm; AOB, aortic occlusion balloon; CPR, cardiopulmonary resuscitation; CT, computed tomography; IVC, inferior vena cava;
MI, myocardial infarction; OR, operating room; OSR, open surgical repair; rEVAR, endovascular repair of ruptured abdominal aortic aneurysm; TEE,
transesophageal echocardiography.
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Clinically, we saw 61% patients back (44/72), with
a median clinical follow-up of 1.5 months (25th-75th
interquartile, 0.56-10.2). Nine patients who did not have
a recent visit to our facility could not be contacted and
were not in the death certiﬁcate database. These patients
were censored at the last contact.
Fourteen endoleaks were discovered among 31.7%
(13/41) of rEVAR patients who underwent postoperative
imaging. Two were type I and were repaired withendovascular techniques during the initial admission for
rAAA. An additional patient was found to have both type
I and III, which were also repaired during the initial admis-
sion. The majority of the remaining endoleaks were type II
(n ¼ 9) and type III (n ¼ 1). The patient with the type III
endoleak was taken to the angiography suite where an
angiogram could not detect the endoleak found on CT
scan. Therefore, the patient was treated conservatively.
All type II endoleaks were treated conservatively, as their
sac diameter did not increase.
Fig 3. Discharge disposition after endovascular repair of ruptured
abdominal aortic aneurysms (rEVARs) vs open surgical repair
(OSR). SNF, Skilled nursing facility.
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facility for secondary interventions: one for enterocutaneous
ﬁstula and small bowel resection, one for groin infection
requiring exploration and sartorius ﬂap, one for type II endo-
leak for which the patient declined repair, one for infected
retroperitoneal hematoma, and two for infected femoral-
femoral bypass that ultimately required explant and redo
bypass. Three patients from the OSR group returned to
our facility for secondary interventions: one with an aorto-
duodenal ﬁstula and graft infection, another with a graft
infection requiring excision, and one with an acute gastroin-
testinal bleed and acute renal failure shortly after discharge.
Multivariate logistic regression revealed that only the
type of procedure performed (rEVAR: odds ratio, 9.96;
95% conﬁdence interval [CI], 2.4-41.3; P ¼ .002) and
absence of preoperative hypotension (odds ratio, 3.77;
95% CI, 1.0-14.0; P ¼ .042) were predictive of discharge
to home, while age (over or under 80), sex, distance
from our facility, time from symptom onset to presentation
at our facility, and previous aortic endovascular or open
repair did not have a signiﬁcant effect.
Kaplan-Meier life table analysis revealed that midterm
survival was signiﬁcantly higher after rEVAR compared
with OSR (P ¼ .01, log-rank) (Fig 4, A). Subgroup
survival analysis evaluating only those patients who
survived past 30 days found similar midterm survival
between groups (P ¼ .7, log-rank).
The 30-day absolute risk reduction for death after
rEVAR compared with OSR in patients with rAAAs
who survived their initial operative intervention was 31%
(95% CI, 0.12-0.48) with a relative risk reduction of 57%
(95% CI, 0.21-0.90). The overall midterm absolute risk
reduction and relative risk reduction for death after rEVAR
compared with open OSR were 25% and 35%, respectively
(95% CI, 0.04-0.42 and 0.06-0.59, respectively).DISCUSSION
There are now several reports, including our own,
demonstrating that rEVAR has improved perioperative
and early survival from rAAA.4-8,16 The perioperative and
30-day survival beneﬁt with rEVAR compared with OSR
in this series is commensurate with the reduction in early
mortality realized in our previously published results.16
The critical questions now are the following: does this early
survival beneﬁt persist through longer follow-up, is it appli-
cable to all patients able who successfully undergo rEVAR,
and how does the type of procedure affect other aspects of
these patients’ postoperative recovery?
Patients who underwent rEVAR were signiﬁcantly
more likely to discharge to home rather than an SNF
compared with those who underwent OSR. To our knowl-
edge, this is the ﬁrst report examining the effect of repair
type on discharge disposition and highlights the physio-
logic beneﬁt of an endovascular approach to this extremely
morbid condition.17 Our patients were 10 times more likely
to go home after rEVAR. Hypotension, which is a marker
for the degree of physiologic insult, was the only other
predictor for discharge to a SNF. The biologic and psycho-
social beneﬁts of rEVAR, including the immediate ability
to ambulate, return to a normal level of independence,
and discharge to home rather than a SNF need further
study to determine its full impact on quality of life. We
are currently undertaking such studies using validated
questionnaires.
We further analyzed the signiﬁcance of a strictly endo-
vascular approach vs that of “hybrid” procedures (ie, only
rEVAR compared with endovascular repair with concomitant
decompression laparotomy and/or femoral-femoral arterial
bypass) in an effort to emphasize the beneﬁt of standalone
endovascular technique. This revealed signiﬁcantly favorable
outcomes following the strictly endovascular approach
compared with the “hybrid” approach including shorter
hospital LOS (10.1 6 11.6 vs 21.4 6 15.3 days; P ¼ .01)
and a lower incidence of discharge to an SNF (29% vs 67%;
P ¼ .001). Patients who underwent decompression lapa-
rotomy were also more likely to die in the hospital, likely
because of the greater severity of their physiologic insult.
Kaplan-Meier survival analysis revealed that the signiﬁ-
cantly improved midterm survival of patients treated with
rEVAR compared with OSR is consistent with the early
survival beneﬁt our rEVAR patients have realized. Subse-
quent Kaplan-Meier group comparison of the subgroup
of patients who lived past 30 days provides further evidence
that the midterm survival beneﬁt of rEVAR is attributable
to the immediate survival advantage afforded by rEVAR
compared with OSR (P ¼ .7, log-rank) (Fig 4, B). Those
who survive the physiologic challenge of rupture and repair
appear to have similar survival. rEVAR allows more of our
patients to survive the initial challenge of aneurysm rupture
and repair and to enter the follow-up period. It is impor-
tant to note that patients who were able to undergo
rEVAR may have had more favorable anatomy than the
OSR group, in particular, less juxtarenal involvement.
Fig 4. A, Midterm survival of patients after endovascular repair of ruptured abdominal aortic aneurysms (rEVARs) or
open surgical repair (OSR) for ruptured abdominal aortic aneurysm (rAAA) (all patients surviving the index procedure).
B, Midterm survival of patients after rEVAR or OSR for rAAA (patients that survived >30 days postdischarge). SEM,
Standard error of the mean.
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for in a randomized trial, which is both impractical and,
given the beneﬁts of EVAR in terms of perioperative and
midterm survival, unethical. Our ﬁndings argue strongly
for the “rEVAR ﬁrst” policy we have described.
Midterm survival may be improved with rEVAR, but
we cannot deﬁnitively say that morbidity improved as
well. Strict follow-up is mandatory to monitor for device
complications such as stent strut fractures, thrombosis,
endoleak, or endograft migration. Patients who underwent
rEVAR may be more susceptible to these complications
than patients who undergo elective EVAR because of the
urgent conditions that preclude advanced planning and
the ability to obtain optimal imaging prior to surgery,
resulting on reliance of alternative techniques like intravas-
cular ultrasound, arteriography, and noncontrast CT scans,
which could in turn lead to a number of patients treated
outside the instructions for use for the device utilized.18-21
The 2009 Society for Vascular Surgery guidelines for
care of patients with AAAs do not detail a recommended
follow-up protocol for patients that survive rEVAR for
rAAA.22 Although the signiﬁcantly shorter hospital (partic-
ularly ICU) course may initially be economically favorable
after rEVAR compared with OSR, the lifelong follow-up
and serial CT evaluation after rEVAR may have high
economic cost, is not without risks such as radiation and
contrast burden, and may be an inconvenience to patients
who have not agreed in advance to interact with the
medical system in this manner for the remainder of their
lives (Fig 5).23,24 In this group of patients, follow-up often
was not achieved.
As the regional referral center for ﬁve states with the
largest land mass catchment area in the United States, wehave the opportunity to see a large number of patients
with aortic pathology. However, our broad catchment
area also introduces limitations. Although our follow-up
for determination of survival was reasonable, we were
unable to account for all of our patients after discharge,
and even those we did account for often had suboptimal
clinical follow-up. Many of our patients receive follow-up
care after rAAA locally and are subsequently lost to our
practice. Problems with follow-up are not unique to our
institution and highlight a major challenge in determining
whether rEVAR is superior to or safer than OSR in the
long term. Lack of sufﬁcient follow-up makes it difﬁcult
to determine the true number of endovascular complica-
tions in our group, and we were unable to determine a reli-
able reintervention rate or the cause of death for the
patients who died outside of our institution. The sample
size of patients with follow-up blood chemistries was too
small to draw meaningful conclusions with regard to
changes in renal function following rEVAR. Additionally,
we do not know the total number of rAAA patients in
our catchment area who were treated in the community
or died before reaching our facility.
Our ﬁndings, while encouraging, may not be generaliz-
able to other practices. As a regional referral center for
acute aortic pathology, our institution has a team trained
and on-call for vascular emergencies 24 hours a day,
a full inventory of stent grafts, and staff accustomed to
caring for critically ill surgical patients.25-27 Although
a recent article has contrarily suggested that rEVAR has
comparable result to OSR, the study was unfortunately
limited by a large percentage of loss to follow-up of those
who underwent open repair.10 Notably, less than 15% of
their patients underwent rEVAR compared with the
Fig 5. Representative ruptured abdominal aortic aneurysm (rAAA) and follow-up images. A, This 61-year-old female
who lived 53 miles from our hospital was woken from sleep by an acute abdominal pain. She was admitted to an outside
hospital where this noncontrast computed tomography (CT) angiography revealed an rAAA. She was transferred to our
hospital and underwent successful endovascular repair of ruptured abdominal aortic aneurysm (rEVAR). B,
Postoperative CT angiography 3 weeks later demonstrated exclusion of the aneurysm sac without endoleak. C, Two-
year follow-up CT angiography revealed decreasing sac diameter. D, Two-year follow-up CT angiography of the chest
revealed an incidental left upper lobe lung nodule that unfortunately turned out to be biopsy-proven adenocarcinoma.
The patient is currently undergoing oncologic workup.
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a structured protocol.28 We have adopted an endovascular-
ﬁrst strategy using aortic occlusion balloons to help control
patients with hemodynamic instability, demonstrating that
patients with hemodynamic instability can be treated using
rEVAR with good results. Finally, although not statistically
signiﬁcant, they did have a trend toward improved early
survival following rEVAR and may not have had the
volume of rEVAR patients to reach statistical signiﬁcance.
Our data show that rEVAR saves lives and support the
utilization of rEVAR over OSR for the treatment of rAAA
when resources, surgeon expertise, and anatomy allow.
More patients are discharged to home after rAAA without
the burden of rehabilitating from a laparotomy incision or
convalescing in an SNF after rEVAR. A signiﬁcantly greater
proportion of patients treated with rEVAR survived to
midterm follow-up than those treated with OSR. Impor-
tantly, the midterm endoleak incidence and signiﬁcance,
and the long-term durability of rEVAR still remain to be
determined. As endovascular surgery becomes increasingly
more prevalent, an effort must be made to continue to
offer the best procedure for each patient whether that be
rEVAR or OSR.29-31CONCLUSIONS
The utilization of rEVAR in our institution has
improved in-hospital and early survival of patients with
rAAAs. We have now demonstrated that a signiﬁcantly
higher proportion of rAAA patients who underwent
rEVAR were able to be discharged home compared with
OSR. At midterm follow-up, the signiﬁcant early survival
beneﬁt of rEVAR for rAAA prevailed. These outcomes
support the utilization of rEVAR over OSR when feasible
in centers that are able to achieve the early survival
beneﬁt. Continued durability, cost-effectiveness, endoleak
incidence and signiﬁcance, and quality of life associated
with rEVAR compared with OSR for rAAA remain to be
determined in late-term follow-up.
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